Grade My Investments
HomeFree Stock Grades › MDWD

MediWound Ltd. (MDWD) Stock Grade

MDWD · Healthcare

A-
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$210.0M
P/E Ratio
Revenue Growth (YoY)
-16.1%
Net Margin
-140.8%
Return on Equity
Dividend Yield
None

About MediWound Ltd.'s fundamentals

MediWound Ltd. is a biotechnology company with a market capitalization of $210.0 million that is currently unprofitable, reporting a net loss in its latest annual statement and a net margin of -140.8%. The company experienced a significant revenue decline of 16.1% year-over-year, indicating contraction in its core business. With no dividend yield and metrics like P/E ratio and return on equity not applicable due to its loss position, the company appears to be in a development or turnaround phase typical of smaller biotech firms.

Track MDWD free — no credit card required. Live grade + monthly AI report →